Press Releases

Trinity Biotech Announces Quarter 1 2022 Financial Results

Download

Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

May 20, 2022

Trinity Biotech Announces The Successful Closing of its Strategic Investment And Partnership With The MiCo Group of South Korea

May 3, 2022

Trinity Biotech announces Quarter 4 and Fiscal Year 2021 Financial Results

April 11, 2022 Download

Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea

April 11, 2022

Trinity Biotech Announces the World Health Organistion Approval Of TrinScreen™ HIV

February 14, 2022

Trinity Biotech Announces The Successful Closing of its Debt Refinancing

January 27, 2022

Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022

January 25, 2022

Trinity Biotech Announces Q3 2021 Financial Results

December 15, 2021

Trinity Biotech Announces Results for Q2, 2021

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results

Trinity Biotech Provides A Business Development Update For Q2 2021

Trinity Biotech Announces Results for Q1, 2021

Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results

Trinity Biotech Announces the Submission of TrinScreen™ HIV to the World Health Organisation for Approval

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results

March 23, 2021

Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results

Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test

Trinity Biotech Announces Results for Q3, 2020